Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Foundation Consumer Healthcare
Foundation Consumer Healthcare
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Alavert
Loratadine
2002-12-19
Allergic rhinitis perennial
,
Urticaria
,
Sinusitis
,
Asthma
,
Common cold
Levonorgestrel
Levonorgestrel
2009-08-28
2024-2040
Prostatic neoplasms
,
Breast neoplasms
,
Menorrhagia
,
Primary ovarian insufficiency
,
Hot flashes
,
Hypogonadism
,
Premature menopause
Plan b
Levonorgestrel
1999-07-28
2024-2040
Prostatic neoplasms
,
Breast neoplasms
,
Menorrhagia
,
Primary ovarian insufficiency
,
Hot flashes
,
Hypogonadism
,
Premature menopause
Plan b one-step
Levonorgestrel
2009-07-10
2024-2040
Prostatic neoplasms
,
Breast neoplasms
,
Menorrhagia
,
Primary ovarian insufficiency
,
Hot flashes
,
Hypogonadism
,
Premature menopause
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use